INVESTIGADORES
CANTIELLO Horacio Fabio
artículos
Título:
Reversal of cystic fibrosis phenotype in a cultured D508 cystic fibrosis transmembrane conductance regulator cell line by oligonucleotide insertion
Autor/es:
PAUL C. ZAMECNIK, MALAY K. RAYCHOWDHURY, DAVID R. TABATADZE, AND HORACIO F. CANTIELLO
Revista:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Referencias:
Año: 2004 p. 8150 - 8155
ISSN:
0027-8424
Resumen:
Cystic fibrosis (CF) is a lethal genetic disorder that is due to mutations in the gene encoding the cAMP-activated anion CF transmembrane conductance regulator (CFTR) channel. A three-nucleotide base deletion (TTT), encoding phenylalanine in position 508 of the translatable CFTR sequence (accompanied by a C to T replacement immediately 5 to the deletion), accounts for 75% of cases of the disease. In the present study, an oligonucleotide complex (CF4–CF6 , 2-0-methyl RNA–unmodified RNA oligonucleotide duplex, respectively) was used to restore CFTR function by insertion of missing bases in 508CFTR mRNA from a cultured (508) cell line. cAMP-activated wholecell currents and Cl transport were detected in CF4–CF6-treated, but not control 508, cells by patch-clamp and 6-methoxy-N-(3-sulfopropyl) quinolinium fluorescence (SPQ) quenching analyses, respectively. Further, the nucleotide addition in the deleted region of 508 CFTR was determined after amplification by RT-PCR. Insertion of UGU and replacement of U by C immediately 5 to the deletion site in 508 mRNAappear to have taken place, with phenotypic but not genotypic reversion in tissue culture of treated cells. The mechanism of insertion of nucleotides has yet to be determined. to the deletion), accounts for 75% of cases of the disease. In the present study, an oligonucleotide complex (CF4–CF6 , 2-0-methyl RNA–unmodified RNA oligonucleotide duplex, respectively) was used to restore CFTR function by insertion of missing bases in 508CFTR mRNA from a cultured (508) cell line. cAMP-activated wholecell currents and Cl transport were detected in CF4–CF6-treated, but not control 508, cells by patch-clamp and 6-methoxy-N-(3-sulfopropyl) quinolinium fluorescence (SPQ) quenching analyses, respectively. Further, the nucleotide addition in the deleted region of 508 CFTR was determined after amplification by RT-PCR. Insertion of UGU and replacement of U by C immediately 5 to the deletion site in 508 mRNAappear to have taken place, with phenotypic but not genotypic reversion in tissue culture of treated cells. The mechanism of insertion of nucleotides has yet to be determined.